PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Jun 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-06-12

Reporting Person: UECKER DARRIN (Director, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-12	Common Stock	X	7365	$2.05	Acquired	877636	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-12	Warrant (right to buy)	$2.05	X	7365	Disposed	2027-06-09	Common Stock (7365)	Direct